Towercrest Capital Management Matinas Bio Pharma Holdings, Inc. Transaction History
Towercrest Capital Management
- $616 Million
- Q2 2024
A detailed history of Towercrest Capital Management transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Towercrest Capital Management holds 1,886,715 shares of MTNB stock, worth $999,958. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,886,715Holding current value
$999,958% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding MTNB
# of Institutions
29Shares Held
33MCall Options Held
0Put Options Held
0-
Highbridge Capital Management LLC New York, NY10.6MShares$5.64 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.32MShares$4.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$1.32 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.29MShares$1.21 Million0.0% of portfolio
-
Alliance Wealth Management Group Flemington, NJ1.89MShares$999,9580.08% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $115M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...